Screening Technology Company IntelliCyt Raises $8M | GenomeWeb

NEW YORK (GenomeWeb News) – Screening technology firm IntelliCyt today said it raised $8 million in a financing round.

New investor Arboretum Ventures led the financing and was joined by existing investors Prolog Ventures, Verge Fund, and New Mexico Community Capital.

Tim Petersen and George Dunbar from Arboretum Ventures are joining IntelliCyt's board in connection to the financing, the Albuquerque, NM-based company said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: carbapenem resistance in Enterobacteriaceae, selection against educational attainment-linked variants, and more.

Technology Review points out that a new US presidential science advisor hasn't been selected.

Researchers find that blood tests might be able to help determine severity of a concussion, Wired reports.

President-elect Donald Trump considers other candidates for director of the National Institutes of Health, Nature News reports.